{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:02:54Z","timestamp":1787166174315,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03597-y","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T11:17:12Z","timestamp":1763205432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Loss of C9orf72 impacts the peripheral neuromuscular system via immune dysregulation and accelerates the progression of amyotrophic lateral sclerosis in SOD-1 mutant mice"],"prefix":"10.1186","volume":"22","author":[{"given":"Francesca","family":"Sironi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Tortarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Mazzucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Camporeale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Freschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Arcadipane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"De Giovanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineko","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Parlanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Podini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Quattrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Bendotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"3597_CR1","doi-asserted-by":"crossref","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22(3):185\u2013212.","DOI":"10.1038\/s41573-022-00612-2"},{"key":"3597_CR2","doi-asserted-by":"crossref","unstructured":"Gentile F, Scarlino S, Falzone YM, Lunetta C, Tremolizzo L, Quattrini A, et al. The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research. Front Neurosci. 2019;13:601.","DOI":"10.3389\/fnins.2019.00601"},{"key":"3597_CR3","doi-asserted-by":"crossref","unstructured":"Nardo G, Trolese MC, De Vito G, Cecchi R, Riva N, Dina G, et al. Immune response in peripheral axons delays disease progression in SOD1G93A mice. J Neuroinflammation. 2016;13(1):261.","DOI":"10.1186\/s12974-016-0732-2"},{"key":"3597_CR4","doi-asserted-by":"crossref","unstructured":"Riva N, Domi T, Pozzi L, Lunetta C, Schito P, Spinelli EG, et al. Update on recent advances in amyotrophic lateral sclerosis. J Neurol. 2024;271(7):4693\u2013723.","DOI":"10.1007\/s00415-024-12435-9"},{"key":"3597_CR5","doi-asserted-by":"crossref","unstructured":"Nguyen HP, Van Broeckhoven C, Van Der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34(6):404\u201323.","DOI":"10.1016\/j.tig.2018.03.001"},{"key":"3597_CR6","doi-asserted-by":"crossref","unstructured":"Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11(4):323\u201330.","DOI":"10.1016\/S1474-4422(12)70043-1"},{"key":"3597_CR7","doi-asserted-by":"crossref","unstructured":"Mizielinska S, Hautbergue GM, Gendron TF, Van Blitterswijk M, Hardiman O, Ravits J, et al. Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics. Lancet Neurol. 2025;24(3):261\u201374.","DOI":"10.1016\/S1474-4422(25)00026-2"},{"key":"3597_CR8","doi-asserted-by":"crossref","unstructured":"Huang M, Liu YU, Yao X, Qin D, Su H. Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications. Transl Neurodegener. 2024;13(1):28.","DOI":"10.1186\/s40035-024-00416-x"},{"key":"3597_CR9","doi-asserted-by":"crossref","unstructured":"Iacoangeli A, Dilliott AA, Al Khleifat A, Andersen PM, Ba\u015fak NA, Cooper-Knock J et al. Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications. J Neurol Neurosurg Psychiatry. 202596(10):928-936.","DOI":"10.1136\/jnnp-2024-335364"},{"key":"3597_CR10","doi-asserted-by":"crossref","unstructured":"Sattler R, Traynor BJ, Robertson J, Van Den Bosch L, Barmada SJ, Svendsen CN, et al. Roadmap for C9ORF72 in frontotemporal dementia and amyotrophic lateral sclerosis: report on the C9ORF72 FTD\/ALS summit. Neurol Ther. 2023;12(6):1821\u201343.","DOI":"10.1007\/s40120-023-00548-8"},{"key":"3597_CR11","doi-asserted-by":"crossref","unstructured":"Breevoort S, Gibson S, Figueroa K, Bromberg M, Pulst S. Expanding clinical spectrum of C9ORF72 -Related disorders and promising therapeutic strategies: A review. Neurol Genet. 2022;8(3):e670.","DOI":"10.1212\/NXG.0000000000000670"},{"key":"3597_CR12","doi-asserted-by":"crossref","unstructured":"Todd TW, Petrucelli L. Insights into the pathogenic mechanisms of chromosome 9 open reading frame 72 (C9orf72) repeat expansions. J Neurochemistry. 2016;138(S1):145\u201362.","DOI":"10.1111\/jnc.13623"},{"key":"3597_CR13","doi-asserted-by":"crossref","unstructured":"Therrien M, Rouleau GA, Dion PA, Parker JA. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. Dupuy D, curatore. PLoS ONE. 2013;8(12):e83450.","DOI":"10.1371\/journal.pone.0083450"},{"key":"3597_CR14","doi-asserted-by":"crossref","unstructured":"Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Annals Neurol. 2013;74(2):180\u20137.","DOI":"10.1002\/ana.23946"},{"key":"3597_CR15","doi-asserted-by":"crossref","unstructured":"Atanasio A, Decman V, White D, Ramos M, Ikiz B, Lee HC, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice. Sci Rep. 2016;6(1):23204.","DOI":"10.1038\/srep23204"},{"key":"3597_CR16","doi-asserted-by":"crossref","unstructured":"O\u2019Rourke JG, Bogdanik L, Y\u00e1\u00f1ez A, Lall D, Wolf AJ, Muhammad AKMG, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351(6279):1324\u20139.","DOI":"10.1126\/science.aaf1064"},{"key":"3597_CR17","doi-asserted-by":"crossref","unstructured":"Burberry A, Suzuki N, Wang JY, Moccia R, Mordes DA, Stewart MH, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. 2016;8(347):347ra93. https:\/\/www.science.org\/doi\/.","DOI":"10.1126\/scitranslmed.aaf6038"},{"key":"3597_CR18","doi-asserted-by":"crossref","unstructured":"Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;23(5):615\u201324.","DOI":"10.1038\/s41593-020-0619-5"},{"key":"3597_CR19","doi-asserted-by":"crossref","unstructured":"Shao Q, Liang C, Chang Q, Zhang W, Yang M, Chen JF. C9orf72 deficiency promotes motor deficits of a C9ALS\/FTD mouse model in a dose-dependent manner. Acta Neuropathol Commun. 2019;7(1):32.","DOI":"10.1186\/s40478-019-0685-7"},{"key":"3597_CR20","doi-asserted-by":"crossref","unstructured":"Shi Y, Lin S, Staats KA, Li Y, Chang WH, Hung ST, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons. Nat Med. 2018;24(3):313\u201325.","DOI":"10.1038\/nm.4490"},{"key":"3597_CR21","doi-asserted-by":"crossref","unstructured":"Banerjee P, Mehta AR, Nirujogi RS, Cooper J, James OG, Nanda J, et al. Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72-ALS iPSC-derived microglia contributes to neurodegeneration. Sci Adv. 2023;9(16):eabq0651.","DOI":"10.1126\/sciadv.abq0651"},{"key":"3597_CR22","doi-asserted-by":"crossref","unstructured":"Sudria-Lopez E, Koppers M, De Wit M, Van Der Meer C, Westeneng HJ, Zundel CAC, et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. 2016;132(1):145\u20137.","DOI":"10.1007\/s00401-016-1581-x"},{"key":"3597_CR23","doi-asserted-by":"crossref","unstructured":"De Marchi F, Munitic I, Amedei A, Berry JD, Feldman EL, Aronica E, et al. Interplay between immunity and amyotrophic lateral sclerosis: clinical impact. Neurosci Biobehav Rev. 2021;127:958\u201378.","DOI":"10.1016\/j.neubiorev.2021.06.027"},{"key":"3597_CR24","doi-asserted-by":"crossref","unstructured":"Langseth AJ, Kim J, Ugolino JE, Shah Y, Hwang HY, Wang J, et al. Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog. Sci Rep. 2017;7(1):5685.","DOI":"10.1038\/s41598-017-05864-2"},{"key":"3597_CR25","doi-asserted-by":"crossref","unstructured":"Suzuki N, Maroof AM, Merkle FT, Koszka K, Intoh A, Armstrong I, et al. The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD. Nat Neurosci. 2013;16(12):1725\u20137.","DOI":"10.1038\/nn.3566"},{"key":"3597_CR26","doi-asserted-by":"crossref","unstructured":"Mordes DA, Morrison BM, Ament XH, Cantrell C, Mok J, Eggan P, et al. Absence of survival and motor deficits in 500 repeat C9ORF72 BAC mice. Neuron. 2020;108(4):775\u2013e7834.","DOI":"10.1016\/j.neuron.2020.08.009"},{"key":"3597_CR27","doi-asserted-by":"crossref","unstructured":"Bauer CS, Cohen RN, Sironi F, Livesey MR, Gillingwater TH, Highley JR, et al. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS\/FTD. Acta Neuropathol. 2022;144(3):437\u201364.","DOI":"10.1007\/s00401-022-02470-z"},{"key":"3597_CR28","doi-asserted-by":"crossref","unstructured":"Pizzasegola C, Caron I, Daleno C, Ronchi A, Minoia C, Carr\u00ec MT, et al. Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph Lateral Scler. 2009;10(4):221\u20138.","DOI":"10.1080\/17482960902803440"},{"key":"3597_CR29","doi-asserted-by":"crossref","unstructured":"Tortarolo M, Re Cecconi AD, Camporeale L, Margotta C, Nardo G, Pasetto L, et al. Sunitinib-mediated Inhibition of STAT3 in skeletal muscle and spinal cord does not affect the disease in a mouse model of ALS. Neurobiol Dis. 2024;199:106576.","DOI":"10.1016\/j.nbd.2024.106576"},{"key":"3597_CR30","doi-asserted-by":"crossref","unstructured":"Cappello V, Marchetti L, Parlanti P, Landi S, Tonazzini I, Cecchini M, et al. Ultrastructural characterization of the lower motor system in a mouse model of Krabbe disease. Sci Rep. 2016;6(1):1.","DOI":"10.1038\/s41598-016-0001-8"},{"key":"3597_CR31","doi-asserted-by":"crossref","unstructured":"Porrello E, Rivellini C, Dina G, Triolo D, Del Carro U, Ungaro D, et al. Jab1 regulates Schwann cell proliferation and axonal sorting through p27. J Experimental Med. 2014;211(1):29\u201343.","DOI":"10.1084\/jem.20130720"},{"key":"3597_CR32","doi-asserted-by":"crossref","unstructured":"Laflamme C, McKeever PM, Kumar R, Schwartz J, Kolahdouzan M, Chen CX et al. Implementation of an antibody characterization procedure and application to the major ALS\/FTD disease gene C9ORF72. eLife. 2019;8:e48363.","DOI":"10.7554\/eLife.48363"},{"key":"3597_CR33","doi-asserted-by":"crossref","unstructured":"Feltri ML, Poitelon Y, Previtali SC. How Schwann cells sort axons: new concepts. Neuroscientist. 2016;22(3):252\u201365.","DOI":"10.1177\/1073858415572361"},{"key":"3597_CR34","doi-asserted-by":"crossref","unstructured":"Curtis R, Stewart HJ, Hall SM, Wilkin GP, Mirsky R, Jessen KR. GAP-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system. J Cell Biol. 1992;116(6):1455\u201364.","DOI":"10.1083\/jcb.116.6.1455"},{"key":"3597_CR35","doi-asserted-by":"crossref","unstructured":"Nardo G, Trolese MC, Verderio M, Mariani A, De Paola M, Riva N, et al. Counteracting roles of MHCI and CD8\u2009+\u2009T cells in the peripheral and central nervous system of ALS SOD1G93A mice. Mol Neurodegeneration. 2018;13(1):42.","DOI":"10.1186\/s13024-018-0271-7"},{"key":"3597_CR36","doi-asserted-by":"crossref","unstructured":"Meyer Zu H\u00f6rste G, Heidenreich H, Mausberg AK, Lehmann HC, Ten Asbroek ALMA, Saavedra JT, et al. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation. Neurobiol Dis. 2010;37(2):483\u201390.","DOI":"10.1016\/j.nbd.2009.11.006"},{"key":"3597_CR37","doi-asserted-by":"crossref","unstructured":"Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A, et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of Familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci. 2003;23(2):180\u201392.","DOI":"10.1016\/S1044-7431(03)00022-8"},{"key":"3597_CR38","doi-asserted-by":"crossref","unstructured":"Hanz S, Perlson E, Willis D, Zheng JQ, Massarwa R, Huerta JJ, et al. Axoplasmic importins enable retrograde injury signaling in lesioned nerve. Neuron. 2003;40(6):1095\u2013104.","DOI":"10.1016\/S0896-6273(03)00770-0"},{"key":"3597_CR39","doi-asserted-by":"crossref","unstructured":"Coque E, Salsac C, Espinosa-Carrasco G, Varga B, Degauque N, Cadoux M, et al. Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc Natl Acad Sci USA. 2019;116(6):2312\u20137.","DOI":"10.1073\/pnas.1815961116"},{"key":"3597_CR40","doi-asserted-by":"crossref","unstructured":"Lobo-Silva D, Carriche GM, Castro AG, Roque S, Saraiva M. Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflammation. 2016;13(1):297.","DOI":"10.1186\/s12974-016-0763-8"},{"key":"3597_CR41","doi-asserted-by":"crossref","unstructured":"Kang Q, Li L, Pang Y, Zhu W, Meng L. An update on Ym1 and its immunoregulatory role in diseases. Front Immunol. 2022;13:891220.","DOI":"10.3389\/fimmu.2022.891220"},{"key":"3597_CR42","doi-asserted-by":"crossref","unstructured":"Sirisi S, Querol-Vilaseca M, Dols\u2010Icardo O, Pegueroles J, Montal V, Mu\u00f1oz L, et al. Myelin loss in C9orf72 hexanucleotide expansion carriers. J Neurosci Res. 2022;100(10):1862\u201375.","DOI":"10.1002\/jnr.25100"},{"key":"3597_CR43","doi-asserted-by":"crossref","unstructured":"Fratta P, Ornaghi F, Dati G, Zambroni D, Saveri P, Belin S, et al. A nonsense mutation in Myelin protein zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function. Hum Mol Genet. 2019;28(1):124\u201332.","DOI":"10.1093\/hmg\/ddy336"},{"key":"3597_CR44","doi-asserted-by":"crossref","unstructured":"Kong L, Valdivia DO, Simon CM, Hassinan CW, Delestr\u00e9e N, Ramos DM et al. Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA. Sci Transl Med. 2021;13(578):eabb6871.","DOI":"10.1126\/scitranslmed.abb6871"},{"key":"3597_CR45","doi-asserted-by":"crossref","unstructured":"Margotta C, Fabbrizio P, Ceccanti M, Cambieri C, Ruffolo G, D\u2019Agostino J et al. Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models. Inflamm Regener. 2023;43(1):19.","DOI":"10.1186\/s41232-023-00270-w"},{"key":"3597_CR46","doi-asserted-by":"crossref","unstructured":"Schreiber S, Schreiber F, Garz C, Debska-Vielhaber G, Assmann A, Perosa V, et al. Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis. Muscle Nerve. 2019;59(5):567\u201376.","DOI":"10.1002\/mus.26444"},{"issue":"4\u20136","key":"3597_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000505777","volume":"82","author":"A Pegat","year":"2019","unstructured":"Pegat A, Bouhour F, Mouzat K, Vial C, Pegat B, Leblanc P, et al. Electrophysiological characterization of C9ORF72-Associated amyotrophic lateral sclerosis: A retrospective study. Eur Neurol. 2019;82(4\u20136):106\u201312.","journal-title":"Eur Neurol"},{"key":"3597_CR48","doi-asserted-by":"crossref","unstructured":"Vahsen BF, Nalluru S, Morgan GR, Farrimond L, Carroll E, Xu Y et al. C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9. Nat Commun. 2023;14(1):5898.","DOI":"10.1038\/s41467-023-41603-0"},{"key":"3597_CR49","doi-asserted-by":"crossref","unstructured":"Yang M, Peyret C, Shi XQ, Siron N, Jang JH, Wu S, et al. Evidence from human and animal studies: pathological roles of CD8\u2009+\u2009T cells in autoimmune peripheral neuropathies. Front Immunol. 2015;6:532. http:\/\/journal.frontiersin.org\/Article\/.","DOI":"10.3389\/fimmu.2015.00532"},{"key":"3597_CR50","doi-asserted-by":"crossref","unstructured":"McCauley ME, O\u2019Rourke JG, Y\u00e1\u00f1ez A, Markman JL, Ho R, Wang X, et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585(7823):96\u2013101.","DOI":"10.1038\/s41586-020-2625-x"},{"key":"3597_CR51","doi-asserted-by":"crossref","unstructured":"K\u00f6nig T, Leutmezer F, Berger T, Zimprich A, Schmied C, St\u00f6gmann E et al. No Association of Multiple Sclerosis with C9orf72 Hexanucleotide Repeat Size in an Austrian Cohort. IJMS. 2023;24(14):11254.","DOI":"10.3390\/ijms241411254"},{"key":"3597_CR52","doi-asserted-by":"crossref","unstructured":"Tiloca C, Sorosina M, Esposito F, Peroni S, Colombrita C, Ticozzi N, et al. No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis. Multiple Scler Relat Disorders. 2018;25:192\u20135.","DOI":"10.1016\/j.msard.2018.07.047"},{"key":"3597_CR53","doi-asserted-by":"crossref","unstructured":"Fenoglio C, De Riz M, Villa C, Serpente M, Ridolfi E, Bonsi R et al. C9ORF72 repeat expansion not detected in patients with multiple sclerosis. Neurobiol Aging. 2014;35(5):1213.e1-1213.e2.","DOI":"10.1016\/j.neurobiolaging.2013.10.096"},{"key":"3597_CR54","doi-asserted-by":"crossref","unstructured":"Ismail A, Cooper-Knock J, Highley JR, Milano A, Kirby J, Goodall E, et al. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J Neurol Neurosurg Psychiatry. 2013;84(1):79\u201387.","DOI":"10.1136\/jnnp-2012-303326"},{"key":"3597_CR55","doi-asserted-by":"crossref","unstructured":"Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol .2019;18(2):211\u201320.","DOI":"10.1016\/S1474-4422(18)30394-6"},{"key":"3597_CR56","doi-asserted-by":"crossref","unstructured":"Beers DR, Henkel JS, Zhao W, Wang J, Appel SH. CD4\u2009+\u2009T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci USA. 2008;105(40):15558\u201363.","DOI":"10.1073\/pnas.0807419105"},{"key":"3597_CR57","doi-asserted-by":"crossref","unstructured":"Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, Del Carro U, et al. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci. 2006;119(19):3981\u201393.","DOI":"10.1242\/jcs.03168"},{"key":"3597_CR58","doi-asserted-by":"crossref","unstructured":"Abo-Rady M, Kalmbach N, Pal A, Schludi C, Janosch A, Richter T, et al. Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 2020;14(3):390\u2013405.","DOI":"10.1016\/j.stemcr.2020.01.010"},{"key":"3597_CR59","doi-asserted-by":"crossref","unstructured":"Collard JF, C\u00f4t\u00e9 F, Julien JP. Defective axonal transport in a Transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995;375(6526):61\u20134.","DOI":"10.1038\/375061a0"},{"key":"3597_CR60","doi-asserted-by":"crossref","unstructured":"De Calbiac H, Renault S, Haouy G, Jung V, Roger K, Zhou Q, et al. Poly-GP accumulation due to C9orf72 loss of function induces motor neuron apoptosis through autophagy and mitophagy defects. Autophagy. 2024;20(10):2164\u201385.","DOI":"10.1080\/15548627.2024.2358736"},{"key":"3597_CR61","doi-asserted-by":"publisher","unstructured":"Xiao S, McKeever PM, Lau A, Robertson J. Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels. Acta Neuropathol Commun. 2019;7:161. https:\/\/doi.org\/10.1186\/s40478-019-0812-5.","DOI":"10.1186\/s40478-019-0812-5"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03597-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:03:25Z","timestamp":1763424205000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03597-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3597"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03597-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were conducted in compliance with the ethical standards of the Mario Negri Institute, where the studies took place. Ethical approval for these procedures was granted by the Animal Welfare Office, Department of Public Health and Veterinary, Nutrition and Food Safety, General Management of Animal Care and Veterinary Drugs at the Italian Ministry of Health (Authorization n.493\/2019-PR issued on July 4, 2019) and Mario Negri Institutional regulations and Policies, providing internal authorisation for persons conducting animal experiments (Quality Management System certificate \u2013 UNI EN ISO 9001:2008 \u2013 reg. N\u00b0 6121), the NIH Guide for the Care and Use of Laboratory Animals (2011 edition), and EU directives and guidelines (EEC Council Directive 2010\/63\/UE).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}